The therapeutic potential of PGC-1α in treating metabolic disorders like T2DM, neurodegenerative diseases, and aging-related decline highlights its importance as a target for therapeutic interventions aimed at improving mitochondrial function and overall metabolic health (Table 3). The gene discussed is PPARGC1A; the disease is Other metabolic disease.